Latest Breaking News On - Onclive scientific interchange - Page 1 : vimarsana.com

BTK Inhibitor Combinations Move to Forefront of CLL Investigations, Conversations

Mazyar Shadman, MD, MPH, details the efficacy of BTK inhibitors in the frontline treatment of CLL as well as safety considerations in the relapsed/refractory setting.

United statesNorth carolinaUniversity of washingtonAlan skarbnikMazyar shadmanAmerican society of hematology annual meeting expositionNovant health in charlotteInternational conference on malignant lymphomaOncology divisionUniversity of washington school medicineInnovators networkOnclive scientific interchangeWorkshop chronic lymphocytic leukemiaLatest dataClinical practiceInnovators network endowed chair

Pellini Discusses Immunotherapies and Current Limitations of ctDNA in Perioperative NSCLC

Pellini Discusses Immunotherapies and Current Limitations of ctDNA in Perioperative NSCLC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Bruna pelliniMorsani college of medicineResearch instituteUniversity of south floridaThoracic oncologyMoffitt cancer centerMorsani collegeSouth floridaOnclive scientific interchange

Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

Emerging data continue to shape perioperative therapy decisions for patients with early-stage non–small cell lung cancer.

United statesStanford universityPamela mielHeather wakeleeGirardn neoadjuvantStanford cancer instituteEuropean lung cancer congressOncology institute of hope innovationScientific interchangeStanford university schoolInternational associationLung cancerOncology instituteOnclive scientific interchangeLung cancer congressNon small cell lung cancer